These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27161454)
1. Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes. Kodama N; Iwao T; Kabeya T; Horikawa T; Niwa T; Kondo Y; Nakamura K; Matsunaga T Drug Metab Pharmacokinet; 2016 Jun; 31(3):193-200. PubMed ID: 27161454 [TBL] [Abstract][Full Text] [Related]
2. Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds. Iwao T; Kodama N; Kondo Y; Kabeya T; Nakamura K; Horikawa T; Niwa T; Kurose K; Matsunaga T Drug Metab Dispos; 2015 Apr; 43(4):603-10. PubMed ID: 25650381 [TBL] [Abstract][Full Text] [Related]
3. Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. Kodama N; Iwao T; Katano T; Ohta K; Yuasa H; Matsunaga T Drug Metab Dispos; 2016 Oct; 44(10):0. PubMed ID: 27417181 [TBL] [Abstract][Full Text] [Related]
4. [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells]. Iwao T Yakugaku Zasshi; 2018; 138(10):1241-1247. PubMed ID: 30270266 [TBL] [Abstract][Full Text] [Related]
5. Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells. Negoro R; Takayama K; Nagamoto Y; Sakurai F; Tachibana M; Mizuguchi H Biochem Biophys Res Commun; 2016 Apr; 472(4):631-6. PubMed ID: 26966071 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method. Iwao T; Toyota M; Miyagawa Y; Okita H; Kiyokawa N; Akutsu H; Umezawa A; Nagata K; Matsunaga T Drug Metab Pharmacokinet; 2014; 29(1):44-51. PubMed ID: 23822979 [TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells. Kabeya T; Qiu S; Hibino M; Nagasaki M; Kodama N; Iwao T; Matsunaga T Drug Metab Dispos; 2018 Oct; 46(10):1411-1419. PubMed ID: 30068521 [TBL] [Abstract][Full Text] [Related]
8. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. Higuchi C; Myoui A; Hashimoto N; Kuriyama K; Yoshioka K; Yoshikawa H; Itoh K J Bone Miner Res; 2002 Oct; 17(10):1785-94. PubMed ID: 12369782 [TBL] [Abstract][Full Text] [Related]
9. An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes. Qiu S; Li Y; Imakura Y; Mima S; Hashita T; Iwao T; Matsunaga T Cells; 2021 Apr; 10(4):. PubMed ID: 33917333 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. Kondo Y; Iwao T; Yoshihashi S; Mimori K; Ogihara R; Nagata K; Kurose K; Saito M; Niwa T; Suzuki T; Miyata N; Ohmori S; Nakamura K; Matsunaga T PLoS One; 2014; 9(8):e104010. PubMed ID: 25084468 [TBL] [Abstract][Full Text] [Related]
11. Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells. Onozato D; Yamashita M; Nakanishi A; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T Drug Metab Dispos; 2018 Nov; 46(11):1572-1580. PubMed ID: 29615438 [TBL] [Abstract][Full Text] [Related]
12. Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies. Yoshida S; Honjo T; Iino K; Ishibe R; Leo S; Shimada T; Watanabe T; Ishikawa M; Maeda K; Kusuhara H; Shiraki N; Kume S Stem Cell Reports; 2021 Feb; 16(2):295-308. PubMed ID: 33513361 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of carboxylesterase in human induced pluripotent stem cell-derived enterocytes. Kabeya T; Matsumura W; Iwao T; Hosokawa M; Matsunaga T Biochem Biophys Res Commun; 2017 Apr; 486(1):143-148. PubMed ID: 28285137 [TBL] [Abstract][Full Text] [Related]
14. Involvement of β-adrenoceptors in the differentiation of human induced pluripotent stem cells into mesodermal progenitor cells. Ishizuka T; Goshima H; Ozawa A; Watanabe Y Eur J Pharmacol; 2014 Oct; 740():28-34. PubMed ID: 25014757 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects. Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268 [TBL] [Abstract][Full Text] [Related]
16. An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity. Kondo Y; Iwao T; Nakamura K; Sasaki T; Takahashi S; Kamada N; Matsubara T; Gonzalez FJ; Akutsu H; Miyagawa Y; Okita H; Kiyokawa N; Toyoda M; Umezawa A; Nagata K; Matsunaga T; Ohmori S Drug Metab Pharmacokinet; 2014; 29(3):237-43. PubMed ID: 24334537 [TBL] [Abstract][Full Text] [Related]